News

良原先生（特任助教）、新崎先生（現：兵庫医科大学消化器内科学講座主任教授）の論文がCrohn’s & Colitis 360誌に掲載されました。
Please refer to the following page for details.

Serum leucine-rich α-2-glycoprotein and monocyte chemoattractant protein-1 as novel biomarkers for predicting vedolizumab response in patients with ulcerative colitis.
Yoshihara T, Shinzaki S, Naka T, Iijima H, Hayashi Y; OGF study group; Ishiguro K, Baba Y, Takehara T; OGF study group.
Crohns Colitis 360. 2026 Aug 11;8(3).